AKT1 and hepatocellular carcinoma: Previous studies have shown the PI3K/AKT path way is overactivated in some HCC cases and PI3K/AKT over-activation is associated with poor prognosis in HCC patients (Minguez et al., 2009; Golob-Schwarzl et al., 2017).